semaglutide aspiration case report anesthesia 2023 Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement Should Wegovy (semaglutide) be stopped

Then comes a period of powerful appetite suppression, rapid weight loss and, for a while, real momentum

2018 Nov;52(6):442-446

Pharmacogenomics J 14 , 5462 (2014)

Improved treatment adherence To achieve significant weight loss results, it is necessary to adhere to the right dose for the right duration

Review article: GLP-1 receptor agonists and glucagon/GIP/GLP-1 receptor dual or triple agonists-mechanism of action and emerging therapeutic landscape in MASLD

Across studies of adults with type 2 diabetes designed to measure A1C reduction, average body weight changes ranged from 7.1 lb to 14.1 lb, though some participants gained weight